Compare NeuPath Health, Inc. with Similar Stocks
Dashboard
1
The company has declared positive results in Mar'2026 after 2 consecutive negative quarters
- NET PROFIT(Q) At CAD 0.48 MM has Grown at 321.06%
- ROCE(HY) Highest at 0.04%
- PRE-TAX PROFIT(Q) At CAD 0.68 MM has Grown at 136.63%
2
With ROE of 2.52%, it has a risky valuation with a 1.22 Price to Book Value
3
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.43%
0%
30.43%
6 Months
15.38%
0%
15.38%
1 Year
135.29%
0%
135.29%
2 Years
207.69%
0%
207.69%
3 Years
263.64%
0%
263.64%
4 Years
100.0%
0%
100.0%
5 Years
-11.76%
0%
-11.76%
NeuPath Health, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.21%
EBIT Growth (5y)
31.88%
EBIT to Interest (avg)
-0.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.93%
ROE (avg)
0.16%
Valuation key factors
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.63
EV to EBIT
15.49
EV to EBITDA
8.09
EV to Capital Employed
1.54
EV to Sales
0.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.93%
ROE (Latest)
4.30%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
21.50
22.10
-2.71%
Operating Profit (PBDIT) excl Other Income
1.40
0.60
133.33%
Interest
0.20
0.20
Exceptional Items
-0.20
-0.20
Consolidate Net Profit
0.40
-0.30
233.33%
Operating Profit Margin (Excl OI)
40.10%
0.30%
3.98%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -2.71% vs 0.00% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 233.33% vs -200.00% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
87.20
72.80
19.78%
Operating Profit (PBDIT) excl Other Income
4.30
3.70
16.22%
Interest
0.90
0.90
Exceptional Items
-1.20
-0.70
-71.43%
Consolidate Net Profit
-0.40
-0.50
20.00%
Operating Profit Margin (Excl OI)
23.40%
19.40%
0.40%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 19.78% vs 10.14% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 20.00% vs -150.00% in Dec 2024
About NeuPath Health, Inc. 
NeuPath Health, Inc.
Finance
NeuPath Health Inc, formerly Klinik Health Ventures Corp, is a Canada-based company. The Company provides chronic pain management services. The Company operates Centres for Pain Management (CPM) and InMedic Creative Medicine in Ontario. The Company’s clinic offers a chronic pain assessment and multi-modal treatment plan to help patients to manage chronic pain.
Company Coordinates 
Company Details
6400 Millcreek Drive, Unit 9 , MISSISSAUGA ON : L5N 3E7
Registrar Details






